IPVV positive | IPVV negative | ||
---|---|---|---|
(n = 18) | (n = 43) | P | |
Age (years) | 70.9 ± 6.8 | 72.4 ± 9.1 | 0.523 |
Female (%) | 1 (5.6) | 16 (37.2) | 0.012 |
Disease duration (months) | 17.5 ± 8.7 | 10.3 ± 7.8 | 0.008 |
Smoking history (years) | 17 (94.4) | 23 (53.5) | 0.002 |
BMI (kg/m^2) | 17.5 ± 2.0 | 24.3 ± 2.7 | 0.008 |
FPG (mmol/L) | 10.8 ± 3.7 | 6.4 ± 1.5 | < 0.001 |
HbA1c (mmol/mol) | 73.1 ± 15.1 | 51.6 ± 11.1 | < 0.001 |
Baseline C-peptide levels (ng/mL) | 1.8 (1.7–1.9) | 2.9 (1.4–8.1) | 0.068 |
fasting insulin (uU/ml) | 10.3 (6.3–14.3) | 10.7 (5.5–17.2) | 1.00 |
TG (mmol/L) | 1.5 ± 1.1 | 1.4 ± 0.6 | 0.605 |
TC (mmol/L) | 4.1 ± 1.3 | 4.5 ± 1.0 | 0.213 |
LDL-C (mmol/L) | 2.3 ± 0.9 | 2.6 ± 0.9 | 0.289 |
HDL-C (mmol/L) | 1.1 ± 0.3 | 1.2 ± 0.3 | 0.419 |
Hcy (umol/L) | 19.8 ± 7.0 | 15.4 ± 5.1 | 0.120 |
SCr (umol/L) | 78.4 ± 17.8 | 113.1 ± 213.4 | 0.549 |
SUA (umol/L) | 352.1 ± 109.6 | 308.5 ± 61.1 | 0.177 |
SUA/SCr | 4.6 ± 1.2 | 4.0 ± 1.2 | 0.171 |
Cys-C (mg/L) | 1.0 ± 0.3 | 1.3 ± 1.0 | 0.312 |
LDH (U/L) | 218.7 ± 32.1 | 199.7 ± 39.3 | 0.159 |
Use of insulin | 8 (44.4) | 9 (20.9) | 0.062 |
HRCT score | 9.2 ± 0.9 | 6.2 ± 2.5 | 0.007 |